Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessStocksNatco Pharma up 8% on USFDA approval for ulcer drug

SHOW NAMES

Trending Topics

business

Natco Pharma up 8% on USFDA approval for ulcer drug

Share prices of Natco Pharma rose 8 percent intraday Thursday on the back of approval received from USFDA for Glycopyrrolate oral tablets.

first published: Jun 23, 2016 10:18 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

New Year Party Or Year-End Blues? Bulls In Focus| Top Stock Bets & 2026 Outlook| Opening Bell Live
Nifty Trades in a Narrow 100-Point Range on 2025’s Final F&O Expiry | Closing Bell Live
Small-Caps & Risk: What Investors Often Miss
Nifty’s Best Case Target & Top Stock Bets For 2026| IPO Wave Set To Get Bigger| Opening Bell Live

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347